|
|
||||||||
Ann Thorac Surg 2004;78:85-89
© 2004 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, University of Bologna, Bologna, Italy
Accepted for publication December 19, 2003.
* Address reprint requests to Dr Chiappini, Department of Cardiovascular Surgery, Policlinico S. Orsola-Malpighi, Via Massarenti 3, 40138 Bologna, Italy
e-mail: bruno_chiappini{at}hotmail.com
| Abstract |
|---|
|
|
|---|
METHODS: We retrospectively identified 115 patients (47 men, 68 women) aged 82.3 ± 2.1 years (mean, 80 to 92 years) who underwent aortic valve replacement alone (71 patients, 62.1%) or in combination with coronary artery bypass grafting (44 patients, 37.9%), between January 1992 and April 2003. These patients had significant severe aortic stenosis with a mean valve area of 0.62 ± 0.15 cm2 and a mean gradient of 88.62 ± 24.06 mm Hg.
RESULTS: The in-hospital mortality rate was 8.5%. The late follow-up was 100% complete. Actuarial survival at 1 and 5 years was 86.4% and 69.4%, respectively. Predictors of late mortality were ejection fraction (p < 0.01), preoperative heart failure (p < 0.03), and the type of prosthesis (p < 0.03).
CONCLUSIONS: The outcome after aortic valve replacement in octogenarians is excellent; the operative risk is acceptable and the late survival rate is good. Therefore, cardiac surgery should not be withheld on the basis of age alone.
| Introduction |
|---|
|
|
|---|
To analyze these issues, we have reviewed our early and long-term results in patients aged 80 years and older who underwent aortic valve replacement (AVR) alone or combined with coronary artery bypass grafting (CABG) for severe aortic stenosis.
| Material and methods |
|---|
|
|
|---|
Urgent operations were defined as operative procedures performed on patients whose accelerated symptoms prompted urgent hospital admission for evaluation and who were judged to be unstable hemodynamically, needing surgical correction within 5 days. In-hospital mortality was considered to be any death occurring within 30 days after surgery. Perioperative myocardial infarction was defined as either a new Q wave or the elevation of the myocardial fraction of creatinine kinase in association with persistent ST segment changes. Stroke was defined as any neurologic deficit lasting longer than 24 hours. Postoperative renal failure was defined as an increase in serum creatinine of more than 2.0 g/dL. Carotid artery stenosis (> 70%), diagnosed by echo-color-Doppler presented in 5 patients (5.2%) undergoing AVR and 2 undergoing AVR+CABG.
All procedures were carried out with cardiopulmonary bypass and at least mild systemic hypothermia (32°C). Cardiac arrest was achieved with cold crystalloid cardioplegia. All procedures were performed via the standard median sternotomy. The selection of the prosthesis type was left to the discretion of the operating surgeon and the preference of the patient. Coronary artery bypass grafting was performed whenever occlusive disease involved major epicardial vessels with a stenosis greater than 60%.
Statistical analysis
Continuous variables were expressed as mean ± 1 standard deviation (SD) and were analyzed by using the unpaired two-tailed t test. Categorical variables were presented as percentages and were analyzed with the
2 test or Fischer's exact test when appropriate. All preoperative and intraoperative variables were first analyzed by using univariate analysis to determine whether any single factor influenced hospital mortality and clinical outcome; p less than 0.05 was considered to indicate statistical significance. Variables which achieved a p value of less than 0.05 in the univariate analysis were examined by using multivariate analysis with forward stepwise logistic regression to evaluate independent risk factors for hospital mortality, and neurologic, respiratory, and renal complications. Statistical analysis was performed with SPSS 8.0 statistical software (SPSS, Chicago, IL).
| Results |
|---|
|
|
|---|
|
Details of the operative procedures are presented in Table 2. Biological prosthesis predominated and a stentless valve was implanted in 12 (10.3%) patients. Thirty-nine percent of the patients more than 80 years received a mechanical prosthesis because of a narrowed aortic annulus or a concomitant atrial fibrillation. The in-hospital mortality (30-day) rate was 8.5%. Seven patients died from cardiac-related causes (n = 4, myocardial infarction; n = 3, cardiac failure). Noncardiac causes of death included pneumonia (n = 2) and cerebrovascular accident (n = 1). Table 3 shows the preoperative variables as predictors of in-hospital death. The mean EF = 35% was the determining factor of in-hospital mortality. The length of stay in the intensive care unit was 3.72 days (1 to 57 days). There were no deaths among patients who remained hospitalized more than 30 days. The follow-up period was 100% complete and it was carried on by telephone interviews performed by well-trained doctors.
|
|
|
|
| Comment |
|---|
|
|
|---|
The decision for surgery is complex in this group of patients and we usually take into account several elements, such as the lack of synchronism between physiologic age and chronologic age, the quality of life, and the risk-benefit ratio. This paper, analyzing the postoperative and long-term outcome of 115 octogenarians undergoing aortic valve replacement, is a contribution to aid in the decision-making process,.
The main surgical indications at our Institution were the aortic valve area (AVA) less than 1 cm2 and the onset of symptoms. The contraindications to refuse surgery were: the deficit of the other organs (kidneys, liver, and lungs); an EF less than 25%; a severely calcified ascending aorta; severe coronary artery disease with no indication for surgery; and refusal of surgery by the patient and his relatives. In this study, we defined the risk factors that would be predictors of early death in this elderly population and we identified them by univariate analysis.
Emergency admission in the very elderly has been shown to be an independent predictor of early mortality [14]. Our study supports this finding as all early deaths occurred in patients whose admission was classified as urgent. These results suggest that elderly patients should be referred for operation as early as possible to prevent urgent operations or advanced stage disease. Urgent surgery has also been predictive of late mortality in other recent studies [14].
The cumulative survival rate was 73% after a mean follow-up time of 37.1 ± 32.4 months. This survival rate is comparable with other studies and shows good long-term survival despite advanced age [1517]. In our patients, we implanted 32 mechanical, 71 biological, and 12 stentless valves.
We believe that the bioprosthetic valve is the safest cardiac valve substitute for octogenarians. Because systemic anticoagulation is rarely required for a long period, bioprosthetic valves have a reduced incidence of bleeding and thrombotic complications as compared to mechanical valves; actually, the patients stopped warfarin intake three months after surgery, switching to 100 mg/die of aspirin [18].
In effect, in the study population in our series, the episodes of thromboembolism and hemorrhage occurred in patients who had received a mechanical prosthesis. Furthermore, at survival analysis, we found a statistically significant difference among patients undergoing AVR with a mechanical prosthesis (56.7%) and those receiving a bioprosthesis (81.7%), (log rank, p = 0.02).
Actually, our policy about the choice of patients is very strict; we prefer to implant the tissue valve in this particular population because we believe the balance risk-benefit is absolutely favorable to biological prosthesis. The indication for implanting a stentless prosthesis exists in patients with a narrowed annulus without a severely calcified aorta, provided that the ejection fraction and the functional status of the other organs are good and if the lifestyle of the patient is active, requiring a prosthesis with the better hemodynamic performance. In patients with a narrowed annulus, impaired organ function, and atrial fibrillation, we prefer to use a mechanical prosthesis to simplify the surgical act and to shorten the operating time.
The perioperative stroke rate is very low (Table 4). This is very interesting because the incidence of stroke after cardiac surgery can be up to 2% of the elderly population without carotid stenosis; but in our study it is 0.8%, which is comparable to that of the younger population. In this type of patient, we avoided manipulating the aorta and we used the atraumatic aortic clamp.
We evaluated the patients' perception of their activity status as well and we found that 98% of the patients who underwent AVR were satisfied with their choice. In terms of functional status, we found that there was a statistically significant improvement of the NYHA class at follow-up in comparison to the preoperative class (2.9 ± 0.6 vs1.6 ± 0.6, p < 0.01).
According to our results and those in the literature concerning elective surgery for aortic valve stenosis, the indications for surgery could be extended (ie, in patients with AVA = 1.2 to 1.4 cm2), because the clinical history of degenerative aortic stenosis in the elderly has a faster evolution than that of rheumatic aortic valve stenosis and because urgent surgery is the most severe risk factor for death.
In summary, we believe that octogenarians with aortic valve disease should not be denied the benefits of surgery if they are reasonably good surgical candidates, are physically and mentally able to stand the stress of surgery, and are motivated to improve their lifestyle. Cardiac surgery can be performed in patients more than 80 years old giving good long-term results, an acceptable mortality, and a good quality of life especially if the indication for surgery is early thus avoiding delays and the risk of impairment of the left ventricular function Table 4.
|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. H. Thourani, R. Myung, P. Kilgo, K. Thompson, J. D. Puskas, O. M. Lattouf, W. A. Cooper, J. D. Vega, E. P. Chen, and R. A. Guyton Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Ann. Thorac. Surg., November 1, 2008; 86(5): 1458 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hata, M. Suzuki, A. Sezai, T. Niino, S. Unosawa, N. Furukawa, and K. Minami Less invasive quick replacement for octogenarians with type A acute aortic dissection. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 489 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Rosengart, T. Feldman, M. A. Borger, T. A. Vassiliades Jr, A. M. Gillinov, K. J. Hoercher, A. Vahanian, R. O. Bonow, and W. O'Neill Percutaneous and Minimally Invasive Valve Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, April 1, 2008; 117(13): 1750 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Grossi, C. F. Schwartz, P.-J. Yu, U. P. Jorde, G. A. Crooke, J. B. Grau, G. H. Ribakove, F. G. Baumann, P. Ursumanno, A. T. Culliford, et al. High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted? Ann. Thorac. Surg., January 1, 2008; 85(1): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Albert, N. Halevy, and E. M. Antman Preoperative Evaluation for Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 261 - 280. [Full Text] |
||||
![]() |
Y. S. Tjang, Y. van Hees, R. Korfer, D. E. Grobbee, and G. J.M.G. van der Heijden Predictors of mortality after aortic valve replacement Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 469 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kolh, A. Kerzmann, C. Honore, L. Comte, and R. Limet Aortic valve surgery in octogenarians: predictive factors for operative and long-term results Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 600 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eitz, D. Fritzsche, G. Kleikamp, A. Zittermann, D. Horstkotte, and R. Korfer Reoperation of the aortic valve in octogenarians. Ann. Thorac. Surg., October 1, 2006; 82(4): 1385 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, A. Rastan, V. Falk, S. Lehmann, J. Garbade, A. K. Funkat, F. W. Mohr, and J. F. Gummert Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 15 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 17, 2006; 47(2): 427 - 439. [Full Text] [PDF] |
||||
![]() |
J. Nagendran, C. Norris, A. Maitland, A. Koshal, and D. B. Ross Is mitral valve surgery safe in octogenarians? Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 83 - 87. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |